Kidney Function and Cerebral Small Vessel Disease in the General Population

Background Anatomic and hemodynamic similarities between renal and cerebral vessels suggest a tight link between kidney disease and brain disease. Although several distinct markers are used to identify subclinical kidney and brain disease, a comprehensive assessment of how these markers link damage at both end organs is lacking. Aim To investigate whether measures of kidney function were associated with cerebral small vessel disease on MRI. Methods In 2526 participants of the population-based Rotterdam Study, we measured urinary albumin-to-creatinine ratio, and estimated glomerular filtration rate based on serum creatinine and cystatin C. All participants underwent brain magnetic resonance imaging. We assessed presence of cerebral small vessel disease by calculating white matter lesion volumes and rating the presence of lacunes and cerebral microbleeds. We used multivariable linear and logistic regression to investigate the association between kidney function and cerebral small vessel disease. Results Worse kidney function was consistently associated with a larger white matter lesion volume (mean difference per standard deviation increase in albumin-to-creatinine ratio: 0·09, 95% confidence interval 0·05; 0·12; per standard deviation decrease in creatinine-based estimated glomerular filtration rate: −0·04, 95% confidence interval −0·08;−0·01, and per standard deviation decrease in cystatin C-based estimated glomerular filtration rate: −0·09, 95% confidence interval −0·13;−0·05). Persons with higher albumin-to-creatinine ratio or lower cystatin C-based estimated glomerular filtration rate levels had a higher prevalence of lacunes (odds ratio per standard deviation increase in albumin-to-creatinine ratio: 1·24, 95% confidence interval 1·07; 1·43). Only participants in the highest quartile of albumin-to-creatinine ratio had a higher frequency of microbleeds compared to the lowest quartile. Conclusions Worse kidney function is associated with cerebral small vessel disease. Of all measures of kidney function, in particular albumin-to-creatinine ratio is related to cerebral small vessel disease.

[1]  Michael F O'Rourke,et al.  Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. , 2005, Hypertension.

[2]  Samuele M. Marcora,et al.  GFR estimation using cystatin C is not independent of body composition. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  Monique M. B. Breteler,et al.  The Rotterdam Study: 2016 objectives and design update , 2015, European Journal of Epidemiology.

[4]  A. Köttgen,et al.  Age, gender, and race effects on cystatin C levels in US adolescents. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[5]  N. Wahlgren,et al.  Stroke and transient ischemic attack , 2013 .

[6]  G. Dell'omo,et al.  Microalbuminuria and endothelial dysfunction in essential hypertension , 1994, The Lancet.

[7]  S. Koh,et al.  Microbleeds and free active MMP‐9 are independent risk factors for neurological deterioration in acute lacunar stroke , 2011, European journal of neurology.

[8]  G. Eknoyan,et al.  Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). , 2005, Kidney international.

[9]  C. DeCarli,et al.  Inflammatory Biomarkers of Vascular Risk as Correlates of Leukoariosis , 2009, Stroke.

[10]  D. Liebeskind,et al.  Strong independent correlation of proteinuria with cerebral microbleeds in patients with stroke and transient ischemic attack. , 2010, Archives of neurology.

[11]  L. Price,et al.  Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  N. Madias,et al.  Serum creatinine as an index of renal function: new insights into old concepts. , 1992, Clinical chemistry.

[13]  Anne Newman,et al.  Cystatin C and subclinical brain infarction. , 2005, Journal of the American Society of Nephrology : JASN.

[14]  S. Takagi,et al.  Relationship between chronic kidney disease and white matter hyperintensities on magnetic resonance imaging. , 2012, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[15]  G. Leoncini,et al.  Microalbuminuria and subclinical cerebrovascular damage in essential hypertension. , 2001, Journal of nephrology.

[16]  Y. Shon,et al.  Impaired kidney function and cerebral microbleeds in patients with acute ischemic stroke , 2009, Neurology.

[17]  D. Spiegelman,et al.  Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. , 2004, Kidney international.

[18]  Wiro J. Niessen,et al.  The Rotterdam Scan Study: design and update up to 2012 , 2011, European Journal of Epidemiology.

[19]  Chang Hun Kim,et al.  Cystatin C, a novel indicator of renal function, reflects severity of cerebral microbleeds , 2014, BMC Neurology.

[20]  Wiro J Niessen,et al.  Kidney Function Is Related to Cerebral Small Vessel Disease , 2008, Stroke.

[21]  Harold I Feldman,et al.  Estimating glomerular filtration rate from serum creatinine and cystatin C. , 2012, The New England journal of medicine.

[22]  Robert J. van Oostenbrugge,et al.  Vascular inflammation in cerebral small vessel disease , 2012, Neurobiology of Aging.

[23]  Jinbiao Zhang,et al.  Serum cystatin C and cerebral microbleeds in patients with acute cerebral stroke , 2014, Journal of Clinical Neuroscience.

[24]  V. Dharnidharka,et al.  Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  Meike W. Vernooij,et al.  The Rotterdam Study: 2014 objectives and design update , 2013, European Journal of Epidemiology.

[26]  C. Price,et al.  Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. , 1995, Kidney international.

[27]  C. DeCarli,et al.  Chronic Kidney Disease Is Associated With White Matter Hyperintensity Volume: The Northern Manhattan Study (NOMAS) , 2007, Stroke.

[28]  T. Kawanami,et al.  Cystatin C as an index of cerebral small vessel disease: results of a cross‐sectional study in community‐based Japanese elderly , 2010, European journal of neurology.

[29]  Michiaki Abe,et al.  Strain vessel hypothesis: a viewpoint for linkage of albuminuria and cerebro-cardiovascular risk , 2009, Hypertension Research.

[30]  D. Y. Lee,et al.  Lipoprotein Phospholipase A2 and Cerebral Microbleeds in the Framingham Heart Study , 2012, Stroke.

[31]  C. Jack,et al.  Associations of microalbuminuria with brain atrophy and white matter hyperintensities in hypertensive sibships , 2008, Journal of the Neurological Sciences.

[32]  K. Borch-Johnsen,et al.  Elevated Urinary Albumin Excretion Is Associated With Impaired Arterial Dilatory Capacity in Clinically Healthy Subjects , 2001, Circulation.

[33]  Xueliang Li,et al.  On a Relation Between , 2012 .

[34]  C. V. van Duijn,et al.  An insulin-like growth factor-I gene polymorphism modifies the risk of microalbuminuria in subjects with an abnormal glucose tolerance. , 2006, European journal of endocrinology.

[35]  W. Ryu,et al.  The Relation between Chronic Kidney Disease and Cerebral Microbleeds: Difference between Patients with and without Diabetes , 2012, International journal of stroke : official journal of the International Stroke Society.

[36]  C. Baylis Nitric oxide deficiency in chronic kidney disease. , 2008, American journal of physiology. Renal physiology.

[37]  G. Sobue,et al.  Microalbuminuria is independently associated with deep or infratentorial brain microbleeds in hypertensive adults. , 2012, American journal of hypertension.

[38]  Wiro J. Niessen,et al.  White matter lesion extension to automatic brain tissue segmentation on MRI , 2009, NeuroImage.

[39]  Takeo Kato,et al.  Microalbuminuria is a risk factor for cerebral small vessel disease in community-based elderly subjects , 2007, Journal of the Neurological Sciences.